Drug class in one race
TIGIT drugs for Non-Small Cell Lung Cancer
2 tracked TIGIT drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the TIGIT page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 1/21 Phase 1
Head-to-head evidence: NK510 vs Sea-tgt